Philip Morris Invests $1.2 Billion In Colorado Campuses, Doubling Its Investment
As it increases production capacity for the Zyn nicotine pouch business, Philip Morris International (PM.N) announced on Monday that it has quadrupled its planned investment in its Colorado manufacturing campus to around $1.2 billion through 2028.
The business first declared in 2024 that it will invest $600 million to construct a Zyn nicotine pouch production facility in Aurora, which opened on Monday.
According to the corporation, the factory manufactures Zyn nicotine pouches and will facilitate exports to markets in the Caribbean, Latin America, and Asia.
According to the corporation, once fully operating, the facility will support 1,000 indirect jobs and have an annual economic effect of almost $550 million.
The Aurora campus will join the company’s current, state-of-the-art nicotine manufacturing facilities in Wilson, North Carolina, and Owensboro, Kentucky, according to the Marlboro manufacturer.
With millions of users, nicotine pouches are the fastest-growing nicotine product in the United States. They drive revenues for Philip Morris and support the company’s expansion into other smoke-free goods, such as vapes and the heated tobacco gadget IQOS.
The investment was made just weeks after the U.S. Food and Drug Administration approved 20 Zyn nicotine pouches as less dangerous than cigarettes, enabling the firm to promote information about lower risk as compared to cigarettes.
Strong demand for smoke-free goods helped Philip Morris surpass second-quarter projections in July